Karl Kieburtz, M.D., M.P.H.

Dr. Karl Kieburtz

585-341-7500 (clinical)
585-275-0553 (academic)

Current Titles and Roles

Professor of Neurology and Community and Preventive Medicine

Degrees, Certifications, and Licenses

  • B.A., Amherst College, 1980
  • M.D., University of Rochester, 1985
  • Internship, Highland Hospital, Family Medicine, 1985-1986
  • Residency, Strong Memorial Hospital, Neurology, 1986-1989
  • Fellowship, Experimental Therapeutics, 1989-1992
  • Certification, Neurology, 1990

Work History

1992-1995, Assistant Professor, Departments of Neurology and Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York

1993- Present, Director, Clinical Trials Coordination Center, Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York

1995-2000, Associate Professor, Departments of Neurology and Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York

1999-2005, Chief, Movement and Inherited Neurological Disorders Unit, Department of Neurology,
University of Rochester School of Medicine and Dentistry, Rochester, New York

2000-Present, Professor, Departments of Neurology and Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York

Clinical Specialties

Movement disorders, HIV infection

Highlights

  • Member, NINDS NSD-K Study Section, 2000-2004
  • Member, FDA Peripheral & Central Nervous System Drugs Advisory Committee, 2003-Present
  • American Society for Experimental NeuroTherapeutics (ASENT), member, 1998
    • ASENT Program Committee, 1999-present
    • ASENT Treasurer, 2003-present
  • American Neurology Association (ANA), member 1996
    • ANA Scientific Program Advisory Committee, 2003-present
  • Movement Disorders Society (MDS)
    • MDS Scientific Issues Committee, 2003-present
    • MDS International Executive Committee, 2004-present
  • American Academy of Neurology, fellow, 1998
  • American Association for the Advancement of Science, 1992
  • Sigma Xi, 1992
  • World Federation of Neurology Research Committee on Parkinson’s Disease & Related Disorders, 2001

Research

  • Treating neurodegenerative diseases affecting the basal ganglia, particularly Parkinson’s disease, Huntington’s disease, and HIV related neurologic disorders
  • Directing the Coordination Center for multi-center academic clinical research consortia

Academic Activity

Fellowship Program: Movement and Inherited Neurological Disorders

Scroll to Top